163 related articles for article (PubMed ID: 36791563)
21. Mixed neuroendocrine-non-neuroendocrine neoplasm of the gallbladder: case report and literature review.
Ren X; Jiang H; Sun K; Qin X; Qu Y; Xia T; Chen Y
Diagn Pathol; 2022 Jun; 17(1):51. PubMed ID: 35715834
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs): A SEER database analysis of 767 cases.
Song H; Yang S; Zhang Y; Hua Y; Kleeff J; Liu Q; Liao Q
Front Oncol; 2022; 12():1007317. PubMed ID: 36698410
[TBL] [Abstract][Full Text] [Related]
23. Mixed Adeno-Neuroendocrine Carcinoma; Case Series of Ten Patients with Review of the Literature.
Düzköylü Y; Aras O; Bostancı EB; Keklik Temuçin T; Ulaş M
Balkan Med J; 2018 May; 35(3):263-267. PubMed ID: 29551754
[TBL] [Abstract][Full Text] [Related]
24. Mixed neuroendocrine-non-neuroendocrine neoplasms of the digestive system: A mini-review.
Toor D; Loree JM; Gao ZH; Wang G; Zhou C
World J Gastroenterol; 2022 May; 28(19):2076-2087. PubMed ID: 35664032
[TBL] [Abstract][Full Text] [Related]
25. Primary Oral Mixed Neuroendocrine-Non-neuroendocrine Neoplasm (MiNEN): A Rare Case Report and Review of the Literature.
Sripodok P; Kouketsu A; Kuroda K; Miyashita H; Sugiura T; Kumamoto H
Head Neck Pathol; 2024 Feb; 18(1):13. PubMed ID: 38393494
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors for survival after curative resection of gastric mixed adenoneuroendocrine carcinoma: a series of 80 patients.
Xie JW; Lu J; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Li P; Huang CM
BMC Cancer; 2018 Oct; 18(1):1021. PubMed ID: 30348122
[TBL] [Abstract][Full Text] [Related]
27. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
Kim JY; Hong SM
Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
[TBL] [Abstract][Full Text] [Related]
28. Mixed neuroendocrine-nonneuroendocrine neoplasms of the gastrointestinal system: An update.
Elpek GO
World J Gastroenterol; 2022 Feb; 28(8):794-810. PubMed ID: 35317101
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological features and prognostic factors associated with gastroenteropancreatic mixed neuroendocrine non-neuroendocrine neoplasms in Chinese patients.
Huang YC; Yang NN; Chen HC; Huang YL; Yan WT; Yang RX; Li N; Zhang S; Yang PP; Feng ZZ
World J Gastroenterol; 2021 Feb; 27(7):624-640. PubMed ID: 33642833
[TBL] [Abstract][Full Text] [Related]
30. Do neuroendocrine carcinomas and mixed neuroendocrine-non-neuroendocrine neoplasm of the gastrointestinal tract have the same prognosis? A
Shi H; Qi C; Meng L; Yao H; Jiang C; Fan M; Pang S; Zhang Q; Lin R
Ther Adv Endocrinol Metab; 2020; 11():2042018820938304. PubMed ID: 32670540
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic and Molecular Characteristics of Gastrointestinal MiNENs.
Yeo MK; Yoon N; Bae GE
Front Oncol; 2021; 11():709097. PubMed ID: 34422662
[TBL] [Abstract][Full Text] [Related]
32. Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms.
La Rosa S; Sessa F; Uccella S
Endocr Pathol; 2016 Dec; 27(4):284-311. PubMed ID: 27169712
[TBL] [Abstract][Full Text] [Related]
33. Primary Biliary Mixed Adenoneuroendocrine Carcinoma (MANEC): A Short Review.
Acosta AM; Wiley EL
Arch Pathol Lab Med; 2016 Oct; 140(10):1157-62. PubMed ID: 27684986
[TBL] [Abstract][Full Text] [Related]
34. Chromosomal and molecular pathway alterations in the neuroendocrine carcinoma and adenocarcinoma components of gastric mixed neuroendocrine-nonneuroendocrine neoplasm.
Sun L; Zhang J; Wang C; Zhao S; Shao B; Guo Y; Liu Y; Sun Y
Mod Pathol; 2020 Dec; 33(12):2602-2613. PubMed ID: 32461621
[TBL] [Abstract][Full Text] [Related]
35. Title: pancreatic-type mixed acinar neuroendocrine carcinoma of the stomach: a case report and review of the literature.
Ooe Y; Watanabe K; Hashimoto I; Takenaka S; Ojima T; Yamamoto S; Fujii H
Diagn Pathol; 2021 Feb; 16(1):11. PubMed ID: 33531019
[TBL] [Abstract][Full Text] [Related]
36. High neuroendocrine component is a factor for poor prognosis in gastrointestinal high-grade malignant mixed adenoneuroendocrine neoplasms.
Chen MH; Kuo YJ; Yeh YC; Lin YC; Tzeng CH; Liu CY; Chang PM; Chen MH; Jeng YM; Chao Y
J Chin Med Assoc; 2015 Aug; 78(8):454-9. PubMed ID: 26002564
[TBL] [Abstract][Full Text] [Related]
37. Neuroendocrine neoplasms of the esophagus and stomach.
Mastracci L; Rindi G; Grillo F; Solcia E; Campora M; Fassan M; Parente P; Vanoli A; La Rosa S
Pathologica; 2021 Feb; 113(1):5-11. PubMed ID: 33686305
[TBL] [Abstract][Full Text] [Related]
38. Retrospective analysis of the clinicopathological characteristics of gastrointestinal neuroendocrine neoplasms.
Wang Z; Li W; Chen T; Yang J; Luo L; Zhang L; Sun B; Liang R
Exp Ther Med; 2015 Sep; 10(3):1084-1088. PubMed ID: 26622444
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine neoplasms of the appendix, colon and rectum.
Volante M; Grillo F; Massa F; Maletta F; Mastracci L; Campora M; Ferro J; Vanoli A; Papotti M
Pathologica; 2021 Feb; 113(1):19-27. PubMed ID: 33686307
[TBL] [Abstract][Full Text] [Related]
40. Endocrine cell carcinomas of the colon and rectum: a clinicopathological evaluation.
Komatsubara T; Koinuma K; Miyakura Y; Horie H; Morimoto M; Ito H; Lefor AK; Sata N; Fukushima N
Clin J Gastroenterol; 2016 Feb; 9(1):1-6. PubMed ID: 26699873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
